Clinical Studies on Foam Sclerotherapy: A Review
Introduction
Varicose veins, a common vascular condition affecting a significant portion of the adult population, are characterized by enlarged, twisted veins, most commonly in the legs. While often considered a cosmetic concern, varicose veins can lead to symptoms such as pain, swelling, heaviness, and in more severe cases, skin changes and ulceration. Various treatment modalities exist, ranging from conservative measures like compression stockings to interventional procedures such as surgical stripping, endovenous laser ablation (EVLA), radiofrequency ablation (RFA), and sclerotherapy. Among these, foam sclerotherapy has emerged as a minimally invasive and effective option, particularly for larger varicose veins. This review aims to synthesize findings from recent clinical studies, evaluating the efficacy, safety, and comparative effectiveness of foam sclerotherapy in the management of venous disease.
Mechanism of Action
Sclerotherapy involves injecting a sclerosant solution directly into the affected vein, causing irritation and inflammation of the vein wall, leading to its collapse and eventual fibrosis. Foam sclerotherapy utilizes a sclerosant mixed with air to create a foam, which offers several advantages over liquid sclerotherapy. The foam displaces blood more effectively, allowing for better contact with the vein wall and requiring a lower concentration and volume of the sclerosant. This enhanced contact and reduced dilution lead to a more potent sclerosing effect, making it suitable for larger veins that might otherwise require surgical intervention. The most commonly used sclerosants for foam preparation include polidocanol and sodium tetradecyl sulfate (STS).
Efficacy of Foam Sclerotherapy
Clinical studies have consistently demonstrated the efficacy of foam sclerotherapy in achieving venous occlusion and improving symptoms associated with varicose veins. A systematic review published in 2006, encompassing over 9,000 patients, reported a median venous occlusion rate of 60% or more across all studies, with English language randomized controlled trials (RCTs) showing a median rate of 84.4% [1]. More recent studies continue to support these findings. For instance, a study evaluating Controlled Venospasm-Assisted Foam Sclerotherapy (CVAFS) combined with high ligation (HL) reported a technical success rate of 100% within 6 weeks and a 1-year occlusion rate of 93.6% [2]. This highlights the potential for high short-to-medium term efficacy, especially with optimized techniques.
However, long-term efficacy, particularly regarding recurrence rates, remains an area of ongoing investigation. The 2006 systematic review noted that longer-term efficacy in terms of recurrence or new varicosities was less certain [1]. While some studies suggest comparable long-term outcomes to other treatments, others indicate a higher risk of new vein development over extended periods. For example, one RCT with a 10-year follow-up found a significantly higher risk of developing new veins after foam sclerotherapy compared to surgery [1]. This underscores the importance of patient selection, technique, and long-term follow-up in optimizing outcomes.
Safety and Complications
Foam sclerotherapy is generally considered safe, with most adverse events being minor and transient. Common local adverse events include minor vein thrombosis, thrombophlebitis, skin matting/staining/pigmentation, and pain at the injection site. Systemic adverse events such as visual disturbance, transient confusion, and headache have also been reported, typically resolving without long-term sequelae [1]. Serious adverse events are rare, occurring in a small percentage of treatments (0-5.7%) [1]. These can include deep vein thrombosis, cutaneous necrosis, and in very rare instances, neurological events or myocardial infarction, though these are exceedingly uncommon [1].
Comparative studies have generally shown that the risk of adverse events with foam sclerotherapy is not significantly different from liquid sclerotherapy or surgery [1]. However, some studies have noted specific differences, such as a higher incidence of visual disturbance with foam sclerotherapy compared to liquid sclerotherapy, and a higher risk of skin matting/staining/pigmentation compared to surgery [1]. Careful patient selection, adherence to recommended sclerosant concentrations and volumes, and proper injection techniques are crucial to minimize the risk of complications.
Comparison with Other Treatments
Foam sclerotherapy is often compared with other established treatments for varicose veins, including endovenous laser ablation (EVLA) and surgical stripping. While medium-term follow-up studies have suggested equivalent recurrence rates and quality of life at 2-3 years among laser ablation, foam sclerotherapy, and surgery, long-term comparative data, especially for foam sclerotherapy, have been more limited [3].
A randomized trial comparing laser ablation, foam sclerotherapy, and surgery found that disease-specific quality of life 5 years after treatment was better after laser ablation or surgery than after foam sclerotherapy [3]. This suggests that while foam sclerotherapy is effective, other modalities might offer superior long-term patient-reported outcomes in certain contexts. However, foam sclerotherapy often presents advantages in terms of being a less invasive, outpatient procedure that avoids general anesthesia, potentially leading to a quicker return to normal activities [1].
Future Directions
Ongoing research in foam sclerotherapy focuses on refining techniques, optimizing sclerosant formulations, and conducting long-term comparative studies. The development of more stable and effective foam formulations is a key area of innovation [4]. Further research is needed to establish standardized protocols, assess the learning curve for new techniques, and conduct formal economic analyses comparing foam sclerotherapy with other treatments [2]. High-quality RCTs with extended follow-up periods are essential to solidify the role of foam sclerotherapy in evidence-based therapeutic algorithms [1, 2].
Conclusion
Foam sclerotherapy represents a valuable and effective minimally invasive treatment option for varicose veins. Clinical studies consistently demonstrate its ability to achieve venous occlusion and improve patient symptoms, with a generally favorable safety profile. While its long-term efficacy, particularly concerning recurrence, warrants further investigation and comparison with other modalities, it offers distinct advantages in terms of procedural simplicity and patient recovery. As research continues to evolve, foam sclerotherapy is poised to maintain its significant role in the comprehensive management of venous disease.
Disclaimer
This blog post is intended for informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this article.
References
[1] Jia, X., Mowatt, G., Ho, V., Cook, J., Fraser, C., & Burr, J. (2006). *Systematic review of the safety and efficacy of foam sclerotherapy for venous disease of the lower limbs*. Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews. National Center for Biotechnology Information. [2] Chen, Y., Liu, Z., Zhu, X., Chen, B., Liu, Z., & Kong, J. (2026). Controlled venospasm-assisted foam sclerotherapy combined with high ligation—a novel minimally invasive approach for primary great saphenous vein varicosities. *Frontiers in Surgery*. [3] Brittenden, J., Cooper, D., Dimitrova, M., Scotland, G., G., Cotton, S. C., Elders, A., ... & Campbell, M. K. (2019). Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins. *New England Journal of Medicine*, 381(10), 912-922. [4] UK Vein Clinic. (2025). *Foam Sclerotherapy: Advanced Varicose Vein Treatment for Lasting Results*. Retrieved from https://www.ukveinclinic.com/blog/innovations-in-foam-sclerotherapy-enhancing-varicose-vein-treatment